AstraZeneca Criticizes HHS For Bid To Skirt Drug Price Suit
AstraZeneca has chided the federal government for seeking a quick win against the drugmaker's challenge to the Medicare drug price negotiation program in a recent brief, arguing that the Centers for...To view the full article, register now.
Already a subscriber? Click here to view full article